Trial Profile
Teriparatide-induced early bone resorptive response for the prediction of 2-year bone density outcome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 20 May 2014 New trial record